(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced MiSeq™, a low-cost personal sequencing system that provides individual researchers a platform with rapid turnaround time, unmatched accuracy, and radically improved ease of use. Leveraging the company’s TruSeq™ sequencing chemistry, the system’s revolutionary workflow offers the flexibility to go from purified DNA to analyzed data in as few as eight hours, or to generate in excess of 1 gigabase per run in slightly over a day. Expected to be priced under $125,000 with individual run prices ranging from $400-$750, MiSeq will be the most affordable next-generation sequencing (NGS) platform available.
